Home

Welcome to ECTRIMS

The European Committee for Treatment and Research in Multiple Sclerosis is a non-profit, independent, representative European-wide organisation that serves as Europe’s and the world’s largest professional organisation dedicated to the understanding and treatment of multiple sclerosis.

View webcasts, abstracts and ePosters at the > ECTRIMS Online Library

Gains by Translation

Roland Martin from the University of Zurich presents the latest MS research in translation, from basic neuroimmunology to disease modifying therapies.

> Watch here

MS Therapy & Monoclonal Antibodies

MS Journal: One way to optimise MS therapy is to implement personalised or extended interval dosing, and monoclonal antibodies are suitable candidates for both.

> Read more

Vaccination Recommendations

Susana-Otero Romero from the MS Center of Catalonia (Cemcat) summarises vaccination recommendations in a soon-to-be published EAN/ECTRIMS initiative.

> Watch here

Digitally United - Wrapping up ECTRIMS 2021

EAN/ECTRIMS Vaccination Standards for MS patients

ECTRIMS 2021:
Be part of an outstanding digital experience 13-15 October 2021

ECTRIMS Focused Workshop 2021 - Highlights

Stay Connected

See below our Twitter-Feed to get the hottest news.

ECTRIMS @ECTRIMS·

17h

Did you know that ECTRIMS is also on LinkedIn? Follow us to learn more about our #MS ... related activities – from #ECTRIMS2022 to #ECTRIMSfellowships – and how we support the #MSResearch and #NeuroScience communities: https://bit.ly/3nWEXAr

ECTRIMS @ECTRIMS·

17 Jan

Controversies in #MS Series: recently published #MSJournal articles debate whether #DMTs ... should be trialed in individuals with #PPMS and #SPMS with or without recent disease activity. One topic, two opinions, one commentary: https://www.ectrims.eu/msjournal/

ECTRIMS @ECTRIMS·

14 Jan

Leading #MSNews: A new study led by @HarvardChanSPH finds that the Epstein-Barr virus ... (#EBV) may be the leading cause of #MS: https://www.hsph.harvard.edu/news/press-releases/epstein-barr-virus-may-be-leading-cause-of-multiple-sclerosis/

ECTRIMS @ECTRIMS·

14 Jan

#MSJournal: Researchers from @HarvardChanSPH, @cemcat_em, @UniBasel_en & La Paz ... University Hospital in Madrid find obesity is associated with faster conversion to MS (MDMS) & a higher relapse rate: https://journals.sagepub.com/doi/abs/10.1177/13524585211061861?journalCode=msja

ECTRIMS @ECTRIMS·

12 Jan

Have you heard? We have shortened our ECTRIMS Twitter handle to EXPAND our conversation ... in the #MS and #NeuroScience community. Continue following us at @ECTRIMS for updates on #ECTRIMS2022, #MSResearch and much more

ECTRIMS @ECTRIMS·

11 Jan

We are getting lean in 2022! We have shortened our handle to @ECTRIMS to expand our ... conversation in the #MS and #NeuroScience community. Continue watching this space for updates on everything from #ECTRIMS2022 to our many MS-related activities

Click here to > Load More

Gains by Translation

MS Therapy & Monoclonal Antibodies

Vaccination Recommendations

Digitally United - Wrapping up ECTRIMS 2021

EAN/ECTRIMS Vaccination Standards for MS patients

ECTRIMS 2021:Be part of an outstanding digital experience 13-15 October 2021

ECTRIMS Focused Workshop 2021 - Highlights

Stay Connected

ECTRIMS 2021:
Be part of an outstanding digital experience 13-15 October 2021